help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 29, 2003
Endocrinology, doi:10.1210/en.2003-0310
A more recent version of this article appeared on September 1, 2003
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
144/9/3783    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vacca, R. A.
Right arrow Articles by Greco, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vacca, R. A.
Right arrow Articles by Greco, M.

Submitted on March 11, 2003
Accepted on May 20, 2003

THYROID HORMONE ADMINISTRATION TO HYPOTHYROID RATS RESTORES THE MITOCHONDRIAL MEMBRANE PERMEABILITY PROPERTIES

Rosa A. Vacca1, Loredana Moro1, Giovanni Caraccio1, Ferruccio Guerrieri1, Ersilia Marra1, and Margherita Greco1*

1 Institute of Biomembranes and Bioenergetics, CNR, Bari, Italy, Department of Medical Biochemistry and Biology, University of Bari, Italy

* To whom correspondence should be addressed. E-mail: csmmmg14{at}area.area.ba.cnr.it.

We have investigated the effect of thyroid hormone on the mitochondrial membrane permeability properties in a hypothyroid rat model. The role played by calcium in affecting these properties has been also examined. Cyclosporin A-sensitive mitochondrial calcium efflux, swelling, and external release of matrix proteins are events that occur normally during the permeability transition process induced by calcium loading of mitochondria. We demonstrate that these events are impaired in mitochondria isolated from the liver of hypothyroid rats, even in the presence of high calcium content. However, after thyroid hormone administration to hypothyroid rats, the mitochondrial permeability transition process in response to calcium loading is restored. Consequently, mitochondrial calcium efflux, swelling and release of matrix proteins, like glutamate dehydrogenase, malate dehydrogenase and aspartate aminotransferase occur. These effects are abrogated by the concomitant administration of Cyclosporin A. The results of the present study suggest that hypothyroidism may be a potential source of adverse effects in patients receiving Cyclosporin A.


Key words: hypothyroidism • calcium • mitochondrial permeability transition • Cyclosporin A







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society